| Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences EV Loftus Jr Gastroenterology 126 (6), 1504-1517, 2004 | 4398 | 2004 |
| Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of … MS Silverberg, J Satsangi, T Ahmad, IDR Arnott, CN Bernstein, SR Brant, ... Canadian Journal of Gastroenterology and Hepatology 19, 5A-36A, 2005 | 4173 | 2005 |
| Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, ... Official journal of the American College of Gastroenterology| ACG 110 (9 …, 2015 | 1959 | 2015 |
| Ustekinumab as induction and maintenance therapy for Crohn’s disease BG Feagan, WJ Sandborn, C Gasink, D Jacobstein, Y Lang, JR Friedman, ... New England journal of medicine 375 (20), 1946-1960, 2016 | 1957 | 2016 |
| The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study WA Faubion Jr, EV Loftus Jr, WS Harmsen, AR Zinsmeister, WJ Sandborn Gastroenterology 121 (2), 255-260, 2001 | 1570 | 2001 |
| ACG clinical guideline: management of Crohn's disease in adults GR Lichtenstein, EV Loftus, KL Isaacs, MD Regueiro, LB Gerson, ... American Journal of Gastroenterology 113 (4), 481-517, 2018 | 1456 | 2018 |
| The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota DA Schwartz, EV Loftus Jr, WJ Tremaine, R Panaccione, WS Harmsen, ... Gastroenterology 122 (4), 875-880, 2002 | 1356 | 2002 |
| Management of Crohn's disease in adults GR Lichtenstein, EV Loftus, KL Isaacs, MD Regueiro, LB Gerson, ... The American journal of gastroenterology 113 (4), 481-517, 2018 | 1285* | 2018 |
| Risk factors for opportunistic infections in patients with inflammatory bowel disease M Toruner, EV Loftus Jr, WS Harmsen, AR Zinsmeister, R Orenstein, ... Gastroenterology 134 (4), 929-936, 2008 | 1267 | 2008 |
| The natural history of adult Crohn's disease in population-based cohorts L Peyrin-Biroulet, EV Loftus Jr, JF Colombel, WJ Sandborn Official journal of the American College of Gastroenterology| ACG 105 (2 …, 2010 | 1173 | 2010 |
| The safety profile of infliximab in patients with Crohn’s disease: the Mayo clinic experience in 500 patients JF Colombel, EV Loftus Jr, WJ Tremaine, LJ Egan, WS Harmsen, ... Gastroenterology 126 (1), 19-31, 2004 | 1139 | 2004 |
| The safety of vedolizumab for ulcerative colitis and Crohn's disease JF Colombel, BE Sands, P Rutgeerts, W Sandborn, S Danese, G D'Haens, ... Gut 66 (5), 839-851, 2017 | 912 | 2017 |
| Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort KT Thia, WJ Sandborn, WS Harmsen, AR Zinsmeister, EV Loftus Jr Gastroenterology 139 (4), 1147-1155, 2010 | 882 | 2010 |
| Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000 CG Loftus, EV Loftus Jr, SW Harmsen, AR Zinsmeister, WJ Tremaine, ... Inflammatory bowel diseases 13 (3), 254-261, 2007 | 859 | 2007 |
| PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis EV Loftus, GC Harewood, CG Loftus, WJ Tremaine, WS Harmsen, ... Gut 54 (1), 91-96, 2005 | 841 | 2005 |
| Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease CA Solem, EV Loftus Jr, WJ Tremaine, WS Harmsen, AR Zinsmeister, ... Inflammatory bowel diseases 11 (8), 707-712, 2005 | 814 | 2005 |
| Crohn's disease in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival EV Loftus Jr, MD Silverstein, WJ Sandborn, WJ Tremaine, WS Harmsen, ... Gastroenterology 114 (6), 1161-1168, 1998 | 797 | 1998 |
| An update on the epidemiology of inflammatory bowel disease in Asia KT Thia, EV Loftus Jr, WJ Sandborn, SK Yang Official journal of the American College of Gastroenterology| ACG 103 (12 …, 2008 | 746 | 2008 |
| Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis BE Sands, L Peyrin-Biroulet, EV Loftus Jr, S Danese, JF Colombel, ... New England Journal of Medicine 381 (13), 1215-1226, 2019 | 740 | 2019 |
| Development of the Crohn's disease digestive damage score, the Lémann score B Pariente, J Cosnes, S Danese, WJ Sandborn, M Lewin, JG Fletcher, ... Inflammatory bowel diseases 17 (6), 1415-1422, 2011 | 732 | 2011 |
William SandbornUniversity of California San Diegoایمیل تأیید شده در ucsd.edu
